https://orcid.org/0000-0002-0013-6552
Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Pooneh Kia, Umme Ruman, Ariyati Retno Pratiwi & Mohd Zobir Hussein. (2023) Innovative Therapeutic Approaches Based on Nanotechnology for the Treatment and Management of Tuberculosis. International Journal of Nanomedicine 18, pages 1159-1191.
Read now
Read now
Shirleen Miriam Marques & Lalit Kumar. (2023) Factors affecting the preparation of nanocrystals: characterization, surface modifications and toxicity aspects. Expert Opinion on Drug Delivery 20:7, pages 871-894.
Read now
Read now
Yang Liu, Shuyuan Shuai, Guiting Huang, Yingchong Chen, Baode Shen & Pengfei Yue. (2021) Nanocrystals based mucosal delivery system: research advances. Drug Development and Industrial Pharmacy 47:11, pages 1700-1712.
Read now
Read now
Articles from other publishers (26)
Yanxue Si, Huize Luo, Pai Zhang, Chunliang Zhang, Juanjuan Li, Peng Jiang, Wenbing Yuan & Ruitao Cha. (2024) CD-MOFs: From preparation to drug delivery and therapeutic application. Carbohydrate Polymers 323, pages 121424.
Crossref
Crossref
Mohit Kumar, Ayah R. Hilles, Samah Hamed Almurisi, Amit Bhatia & Syed Mahmood. (2023) Micro and nano-carriers-based pulmonary drug delivery system: Their current updates, challenges, and limitations – A review. JCIS Open 12, pages 100095.
Crossref
Crossref
Ludan Yue, Xueyang Zhang, Chenchen Zhao, Rongchang Chen, Xiaoyuan Chen & Lang Rao. (2023) Inhaled drug delivery: Past, present, and future. Nano Today 52, pages 101942.
Crossref
Crossref
Yonghui Zhang, Tongde Du, Na Liu, Juan Wang, Lingqiang Zhang, Chun-Ping Cui, Chaonan Li, Xin Zhang, Bo Wu, Jinhao Zhang, Wenli Jiang, Yubing Zhang, Yuting Zhang, Hongchang Li & Peiyu Li. (2023) Discovery of an OTUD3 inhibitor for the treatment of non-small cell lung cancer. Cell Death & Disease 14:6.
Crossref
Crossref
Gamaleldin I. Harisa, Abdelrahman Y. Sherif, Fars K. Alanazi, Essam A. Ali, Gamal A. Omran, Fahd A. Nasr, Sabry M. Attia & Ali S. Alqahtani. (2023) TPGS decorated NLC shift gefitinib from portal absorption into lymphatic delivery: Intracellular trafficking, biodistribution and bioavailability studies. Colloids and Surfaces B: Biointerfaces 223, pages 113148.
Crossref
Crossref
Heba A. Gad. 2023. Nanotechnology Principles in Drug Targeting and Diagnosis. Nanotechnology Principles in Drug Targeting and Diagnosis
213
236
.
Thashree Marimuthu, Lisa C. du Toit & Yahya E. Choonara. 2023. Advanced Nanoformulations. Advanced Nanoformulations
209
239
.
Akshada S. Mhaske & Rahul Shukla. 2023. Handbook of Oncobiology: From Basic to Clinical Sciences. Handbook of Oncobiology: From Basic to Clinical Sciences
1
21
.
Priya Shrivastava, Laxmikant Gautam, Sonal Vyas & Suresh P. Vyas. 2023. Tubercular Drug Delivery Systems. Tubercular Drug Delivery Systems
145
171
.
Tasleem, Nithya Shanthi, Arun Kumar Mahato & Richa Bahuguna. (2022) Oral delivery of butoconazole nitrate nanoparticles for systemic treatment of chronic paracoccidioidomycosis: A future aspect. Journal of Drug Delivery Science and Technology 77, pages 103808.
Crossref
Crossref
Yong-Bo Zhang, Dong Xu, Lu Bai, Yan-Ming Zhou, Han Zhang & Yuan-Lu Cui. (2022) A Review of Non-Invasive Drug Delivery through Respiratory Routes. Pharmaceutics 14:9, pages 1974.
Crossref
Crossref
Dhananjay Yadav, Peninah M. Wairagu, Minseok Kwak & Jun-O Jin. (2022) Nanoparticle-Based Inhalation Therapy for Pulmonary Diseases. Current Drug Metabolism 23:11, pages 882-896.
Crossref
Crossref
Snehal K Shukla, Veronica Nguyen, Mimansa Goyal & Vivek Gupta. (2022) Cationically modified inhalable nintedanib niosomes: enhancing therapeutic activity against non-small-cell lung cancer. Nanomedicine 17:13, pages 935-958.
Crossref
Crossref
Deepthi Alapati & Thomas H. Shaffer. (2022) Administration of Drugs/Gene Products to the Respiratory System: A Historical Perspective of the Use of Inert Liquids. Frontiers in Physiology 13.
Crossref
Crossref
Manish Kumar, Abhishek Jha, Kanchan Bharti, Gourav Parmar & Brahmeshwar Mishra. (2022) Advances in lipid-based pulmonary nanomedicine for the management of inflammatory lung disorders. Nanomedicine 17:12, pages 913-934.
Crossref
Crossref
Forough N Golafzani, Ali Z Vaziri, Masoud Javanmardi, Fatemeh Seyfan, Mahboubeh Yazdanifar & Sepideh Khaleghi. (2022) Delivery of miRNA-126 through folic acid-targeted biocompatible polymeric nanoparticles for effective lung cancer therapy. Journal of Bioactive and Compatible Polymers 37:3, pages 168-188.
Crossref
Crossref
Regina Scherließ, Simon Bock, Nicholas Bungert, Anna Neustock & Lena Valentin. (2022) Particle engineering in dry powders for inhalation. European Journal of Pharmaceutical Sciences 172, pages 106158.
Crossref
Crossref
Mohammed Asadullah Jahangir, Syed Sarim Imam, Abdul Muheem, Ananda Chettupalli, Fahad A. Al-Abbasi, Muhammad Shahid Nadeem, Imran Kazmi, Muhammad Afzal & Sultan Alshehri. (2020) Nanocrystals: Characterization Overview, Applications in Drug Delivery, and Their Toxicity Concerns. Journal of Pharmaceutical Innovation 17:1, pages 237-248.
Crossref
Crossref
Shadab Md, Nabil A. Alhakamy, Shahid Karim, Gamal A Gabr, Mohammad Kashif Iqubal & Samar S. A. Murshid. (2021) Signaling Pathway Inhibitors, miRNA, and Nanocarrier-Based Pharmacotherapeutics for the Treatment of Lung Cancer: A Review. Pharmaceutics 13:12, pages 2120.
Crossref
Crossref
Amina Vazda, Wei Xia & Håkan Engqvist. (2021) The use of heat to deliver fentanyl via pulmonary drug delivery. International Journal of Pharmaceutics: X 3, pages 100096.
Crossref
Crossref
Hesham A. Saafan, Kamilia M. Ibrahim, Yasmeena Thabet, Sara M. Elbeltagy, Rana A. Eissa, Ashraf H. Ghaleb, Fathy Ibrahim, Mahmoud Elsabahy & Noura G. Eissa. (2021) Intratracheal Administration of Chloroquine-Loaded Niosomes Minimize Systemic Drug Exposure. Pharmaceutics 13:10, pages 1677.
Crossref
Crossref
Sheersha Pramanik, Sourav Mohanto, Ravi Manne, Rahul R. Rajendran, A. Deepak, Sijo Joy Edapully, Triveni Patil & Oly Katari. (2021) Nanoparticle-Based Drug Delivery System: The Magic Bullet for the Treatment of Chronic Pulmonary Diseases. Molecular Pharmaceutics 18:10, pages 3671-3718.
Crossref
Crossref
Elif GÜNGÖR, Resul SEVİNÇEK & Hülya KARA SUBASAT. (2021) New Compound of Pyridine-4-Boronic Acid Cation and Pt(CN)4 Anion Salt: Synthesis, Structural Properties, Hirshfeld Surface Analysis and Density Functional Theory Calculations. Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi 11:3, pages 1990-2000.
Crossref
Crossref
Sedigheh Ehsanimehr, Peyman Najafi Moghadam, Wim Dehaen & Vahid Shafiei‐Irannejad. (2021) Redox and pH‐Responsive NCC/L‐Cysteine/CM‐β‐CD/FA Contains Disulfide Bond‐Bridged as Nanocarriers for Biosafety and Anti‐Tumor Efficacy System. Starch - Stärke 73:9-10.
Crossref
Crossref
Fakhara Sabir, Maimoona Qindeel, Mahira Zeeshan, Qurrat Ul Ain, Abbas Rahdar, Mahmood Barani, Edurne González & M. Ali Aboudzadeh. (2021) Onco-Receptors Targeting in Lung Cancer via Application of Surface-Modified and Hybrid Nanoparticles: A Cross-Disciplinary Review. Processes 9:4, pages 621.
Crossref
Crossref
Jyothsna Manikkath. (2021) Innovations in drug-device combinations for delivering medication to the airways. Airway 4:1, pages 13.
Crossref
Crossref